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Abstract
Amphetamine-induced neuroadaptations involve vascular damage, neuroinflammation, a hypo-
functioning prefrontal cortex (PFC) as well as cognitive alterations. Brain angiotensin II, through 
Angiotensin Type 1 receptor (AT1-R), mediates oxidative/inflammatory responses, promoting 
endothelial dysfunction, neuronal oxidative damage and glial reactivity. The present work aims to 
unmask the role of AT1-R in the development of amphetamine-induced changes over glial and 
vascular components within PFC and hippocampus. Attention deficit was evaluated as a 
behavioral neuroadaptation induced by amphetamine. Brain microvessels were isolated to further 
evaluate vascular alterations after amphetamine exposure. Male Wistar rats were administered 
with AT1-R antagonist, Candesartan, followed by repeated amphetamine. After one week drug-off 
period, animals received a saline or amphetamine challenge and were evaluated in behavioral 
tests. Afterwards, their brains were processed for cresyl violet staining, CD11b (microglia 
marker), GFAP (astrocyte marker) or von Willebrand factor (vascular marker) 
immunohistochemistry, and oxidative/cellular stress determinations in brain microvessels. 
Statistical analysis was performed by using Factorial ANOVA followed by Bonferroni or Tukey 
tests. Repeated amphetamine administration increased astroglial and microglial markers 
immunoreactivity, increased apoptotic cells and promoted vascular network rearrangement at the 
PFC concomitantly with an attention deficit. Although, the amphetamine challenge improved the 
attentional performance, it triggers detrimental effects probably because of the exacerbated 
malondialdehyde levels and increased heat shock protein 70 expression in microvessels. All 
observed amphetamine-induced alterations were prevented by the AT1-R blockade. Our results 
support the AT1-R involvement in the development of oxidative/inflammatory conditions triggered 
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Introduction
Amphetamines constitute a group of drugs associated with clinical use and illicit consumption, 
being D-Amphetamine (Amph) the simplest compound presenting all the chemical properties that 
underlie their physiological actions (Berman et al., 2009; Carvalho et al., 2012). In rodents, Amph 
has long been used as a pharmacological tool to promote dopamine (DA)-imbalance which 
modifies future responses to pharmacological and environmental stimuli (Kalivas, 2007). 
Currently, these neuroadaptations -including cellular, molecular and metabolic modifications- are 
considered to take place along with neuroinflammation (Clark et al., 2013; Loftis & Janowsky, 
2014). Within the central nervous system (CNS), astrocytes, microglia and endothelial cells sense 
disturbed neuronal activity following injury, disease or neurotoxic agents (Clark et al., 2013; 
Shaerzadeh et al., 2018). Besides the increase in DA neurotransmission, in brain areas receiving 
dopaminergic inputs, Amph promotes astrocyte reactivity stimulating cytokine production (Kadota 
& Kadota, 2004; Vicente-Rodriguez et al., 2016; Du et al., 2017; Shah et al., 2012). Furthermore, 
microglial activation has been proposed as a hallmark for Amph derivatives-induced neurotoxicity 
(Thomas et al., 2004), while gene and protein analyses in microglial cells indicate increased 
cytokine production and nitrosative stress after Amph exposure (Tocharus et al., 2008; Wisor et 
al., 2011). At vascular level, increased pro-inflammatory markers, oxidative stress, and heat shock 
proteins expression were reported in meninges-associated vasculature of rodents 24h after non-
toxic doses of Amph (Thomas et al., 2009; Thomas et al., 2010). Interestingly, chronic 
methylphenidate -at an equivalent clinical dosage used to treat attention deficit in humans- 
promotes vascular, glial and neuronal changes in rats (Coelho-Santos et al., 2019).
Altered brain connectivity and neuropsychiatric impairments associated with Amph depend on 
the administration schedule and off-drug periods, showing regional sensitivity and time-dependent 
characteristics (Berman et al., 2008; Shaerzadeh et al., 2018). Compelling evidence indicates that 
decreased neuronal integrity and compromised glial activity in prefrontal cortex (PFC) are a 
common hallmark among Amph users (Sailasuta et al., 2010; Mackey & Paulus, 2013). 
Furthermore, cell death, loss of dopaminergic endings and elevated levels of pro-inflammatory 
markers, were reported in limbic areas -including PFC- after chronic Amph exposure in rodents 
(Kim & Mandyam, 2014; Valvassori et al., 2015). Indeed, cortical alterations involving 
inflammation, oxidative stress, and hypo-perfusion have been associated with mood disorders and 
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Loftis, 2014). Nevertheless, hippocampus (HPC) -implicated in spatial navigation and cognitive 
processes- also displays neurovascular and glial alterations after Amph exposure (Che et al., 2013; 
de Souza Gomes et al., 2015; Coelho-Santos et al., 2019).   
In the last decades, brain Angiotensin II (AngII) has come into focus as a pleiotropic system 
through Angiotensin Type 1 receptor (AT1-R) activation. In pathological conditions, AT1-R 
expressed in astrocytes, microglia and brain endothelial cells emerge as key mediator in the 
development of an oxidative/inflammatory microenvironment and glial activation (Zhou et al., 
2005; von Bohlen und Halbach & Albrecht, 2006). In this sense, glial reactivity elicited by LPS in 
cell cultures, involves the activation and up-regulation of AT1-R, NFκB signaling, further 
production of cytokines and reactive oxygen species (ROS) (Bhat et al., 2016). In the 
spontaneously hypertensive rats (SHR) strain, the AT1-R overexpression in brain microvessels is 
consistent with vascular oxidative stress and inflammation (Zhou et al., 2005). In this scenario, 
AT1-R mediates nitric oxide (NO) imbalance (Yamakawa et al., 2003), vascular increased 
permeability and inflammatory cells recruitment and activation (Ando et al., 2004a; Ando et al., 
2004b). Particularly, AT1-R promotes the initiation and progression of local brain inflammatory 
and oxidative responses under DA-imbalance conditions, as described in animal models of 
senescence (Labandeira-Garcia et al., 2011) and Parkinson’s disease (Labandeira-Garcia et al., 
2012). 
Our previous reports support the AT1-R involvement in the development of Amph-induced 
neuroadaptations at neurochemical, structural and behavioral levels (Paz et al., 2011; Paz et al., 
2013; Occhieppo et al., 2017). Moreover, a long-lasting overexpression of functional AT1-R was 
observed in DA-innervated areas after Amph exposure (Paz et al., 2014), whereas altered AT1-R 
functionality was described regarding classical AngII-elicited actions (Casarsa et al., 2015). In the 
present study, we aimed to characterize the pattern of Amph-induced deleterious effects, over 
microglia and astrocyte activation along with vascular network organization in PFC and HPC; and 
how the AT1-R modulates those effects. Additionally, Amph-induced oxidative and cellular stress 
responses were studied in isolated brain microvessels. Moreover, behavioral tests were performed 
to assess attentional deficit as a functional outcome of PFC activity, which is considered as the 
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Adult male Wistar rats (250–320g), from the Department of Pharmacology vivarium (Facultad 
de Ciencias Químicas, Universidad Nacional de Córdoba, Argentina), were randomly housed in 
groups of four one week before the beginning of the experimental protocol. Throughout the 
experiment, animals were maintained at controlled environmental conditions (20–24°C, 12h 
light/dark cycle with lights on at 07 a.m.) with free access to food and water.
All procedures were approved by Animal Care and Use Committee of the Facultad de Ciencias 
Químicas, Universidad Nacional de Córdoba, Argentina (Res nº 46/15), in accordance with the 
NIH Guide for the Care and Use of Laboratory Animals. 
Drugs
The selective AT1-R antagonist, Candesartan cilexetil (CV, Laboratorios Phoenix, Buenos 
Aires, Argentina), was dissolved in 0.1N NaHCO3 (vehicle, Veh). D-amphetamine sulfate (Amph) 
was dissolved in 0.9% NaCl (saline, Sal) immediately before use. The selected doses were chosen 
considering previous works (Marchese et al., 2016).
Experimental design
In order to evaluate the involvement of AT1-R in the development of Amph-induced long-term 
effects, the animals received oral administration of Veh/CV (3mg/kg by gavage, using a feeding 
needle) once a day during 5 days. From day 6 to day 10, they were daily injected with Sal/Amph 
(2.5mg/kg i.p.) and left undisturbed in their home cages for a drug-free period of 1 week until the 
day of the experiment. Then, four groups were conformed: Veh-Sal; Veh-Amph; CV-Sal and CV-
Amph. On day 17, the animals were tested for behavioral performance after a Sal/Amph 
(0.5mg/kg i.p) challenge and brain samples were taken for immunohistochemistry or cresyl violet 
staining. Additionally, brain microvessels were isolated at day 17 to evaluate the putative 
oxidative and cellular stress evidenced by the Amph challenge (saline i.p., Sal, was considered for 
basal responses).
Immunohistochemistry 
GFAP and CD11b immunohistochemistry
Animals were anesthetized with chloral hydrate (400mg/kg i.p.) and transcardially perfused 
with 200ml of saline and heparin (200µl/l), followed by 250 ml of 4% paraformaldehyde in 0.1M  
Phosphate-Buffer (PB, pH 7.4). Brains were removed and then stored at 4°C in a 30% sucrose 
solution. Coronal sections of 20µm were cut using a freezing microtome (Leica CM1510S), and 
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10% H2O2 and 10% methanol for 2h and then incubated in 10% Normal Goat Serum (NGS; 
Natocor, Córdoba, Argentina) in 0.1M PBS for 2h, to block nonspecific binding sites. The free-
floating sections were incubated overnight, at room temperature, with: mouse monoclonal anti-
Glial Fibrillary Acidic Protein (GFAP) (1:1000; Sigma-Aldrich, MO, USA) or mouse monoclonal 
anti-CD11b (1:1000; Millipore, CA, USA). The next day, the sections were rinsed with 0.01M 
PBS and incubated with biotin-labeled goat anti-mouse secondary antibody (Jackson Immune 
Research, Laboratories Inc, PA, USA) diluted 1:3000 in 2% NGS-0.1M PBS, and Avidin-Biotin-
peroxidase Complex (ABC-Vector Laboratories, CA, USA) for 2h each one, at room temperature. 
The peroxidase label was detected with diaminobenzidine hydrochloride (Sigma-Aldrich, MO, 
USA) and hydrogen peroxide; the solution was intensified with 1% cobalt chloride and 1% nickel 
ammonium sulfate. Finally, the free-floating sections were mounted on gelatinized slides, air-dried 
overnight, dehydrated, cleared in xylene, and placed under a cover slip with DPX mounting 
medium (Flucka Analytical). 
von Willebrand Factor immunohistochemistry
Animals were sacrificed by decapitation and their brains were removed, snap-frozen and stored 
at -70°C until use. Coronal sections of 40µm were cut using the freezing microtome, mounted on 
gelatinized slides and fixed with methanol (15 min at -20ºC). They were placed in a mixture of 
10% H2O2 and 10% methanol for 2h and, after 3 washes in 0.01M Tris-Buffered Saline (TBS), the 
samples were incubated in 10% NGS in 0.1M TBS for 2h. Mounted sections were incubated 
overnight with a rabbit anti-von Willebrand factor antibody (Dako Denmark A/S), diluted 1:200 in 
0.1M TBS, containing 2% NGS and 0.3% Triton X-100 (Flucka Analytical). Then, they were 
incubated with biotin-labeled anti-rabbit secondary antibody (Vector Laboratories, CA, USA) 
diluted 1:500 in 2% NGS-0.1M TBS; and later with ABC, diluted 1:200 in 2% NGS-0.1M TBS, 
for 2h each at room temperature. The peroxidase label was detected as above mentioned and the 
mounted sections were air-dried overnight, dehydrated, cleared in xylene, and placed under a 
cover slip with DPX mounting medium. 
Cresyl violet staining
Coronal sections of 20µm were collected simultaneously from brains used for 
immunohistochemistry. Slices were mounted on gelatinized slides and air-dried overnight. To 
rehydrate, the mounted sections were dipped in distilled water for 10min. Samples were stained 
with cresyl violet (Sigma-Aldrich, MO, USA) for 2min and dipped in water. After staining, slides 









This article is protected by copyright. All rights reserved
alcohol (1min) and 100% alcohol (1min). Finally, the mounted sections were air-dried overnight, 
dehydrated and cleared in xylene, and placed under a cover slip with DPX mounting medium. 
Brain microvessels determinations 
Isolation of brain microvessels
The procedure was performed as described elsewhere by other authors (Zhou et al., 2005). 
Briefly, animals were anesthetized with chloral hydrate (400mg/kg i.p.) and perfused with 30 ml 
of saline. Brains were removed discarding cerebellum, rinsed and homogenized. The homogenate 
was centrifuged twice at 1000g for 10 min, with 3 volumes of cold isotonic sucrose buffer 
(0.32mol/L sucrose, 3mmol/L HEPES in PBS, pH 7.4) each time and the supernatants in-between 
were discarded. Then, the precipitate was re-suspended in sucrose buffer and centrifuged twice for 
30 sec. at 100g. The supernatants were pooled, washed twice with sucrose buffer and once with 
0.1% bovine serum albumin in PBS at 200g for 2min each step. Finally, the pellet was re-
suspended in 0.1% bovine serum albumin in PBS and centrifuged at 14000g for 10min and 
precipitate was stored at −70°C until use. This technique allows the isolation of small-caliber 
vessels that are mainly constituted only by endothelial cells.
Immunofluorescence 
Brain microvessels were mounted on microscope slides positive charged under a magnifying 
glass and dried at 37ºC. The following steps were carried out on a wet chamber and sheltered from 
light. Microvessels were exposed to 1% bovine serum albumin in PBS for 1h, rinsed twice and 
incubated overnight at 4ºC with: mouse monoclonal anti-AT1-R (1:100, provided by Dr. Hans 
Imboden), or mouse monoclonal anti-heat shock protein 70 (HSP70, 1:400, Sigma-Aldrich, MO, 
USA). The next day, the microvessels were rinsed twice with PBS-0.05% tween followed by one 
rinse with PBS, 5min, and incubated for 30min at room temperature with the secondary antibody 
anti-mouse (1:400; Alexa Fluor 555-Abcam). Then, the microvessels were rinsed and incubated 
with Hoechst (1:3000) for 7min. Finally, cover-slips were placed using 90% glycerol as mounting 
media and images were immediately obtained.  
Lipid Peroxidation 
Malondialdehyde (MDA) content was determined by thiobarbituric acid (TBA) reaction as 
previously described (Ohkawa et al., 1979). Briefly, the microvessels isolated at room temperature 
were resuspended in 1.15% KCl and homogenized for 10min. An aliquot was reserved for protein 
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3.5- and 0.8% TBA were added to the remaining homogenate. Samples were heated at 95ºC for 
1h, cooled afterwards and centrifuged at 4000 r.p.m. The colored product absorbance at 532nm 
was estimated and MDA content (nmol/protein μg) was calculated. External standard of 
tetramethoxy-propane was used for the calibration curve.
Image processing 
All the images were obtained by using a Leica DM 4000B microscope equipped with Leica 
FW4000 and a DFC Leica digital camera attached to a contrast enhancement device and 
digitalized images were stored in a computer. All the images were obtained with identical 
exposure times, gain and offsets, and saved in TIFF format (1392 x 1040 pixels). The images were 
processed using ImageJ software (U.S. National Institutes of Health, USA). The analyses were 
made blinded to the experimental groups.
Image quantification was performed in infra- and pre-limbic PFC (Bregma: 3.20mm) and HPC 
(Bregma: −3.30/−3.60 mm), which were identified and delimited according to Paxinos and 
Watson atlas (2009). The measurements were taken bilaterally in two sections and the final value 
was obtained as the average of the four counted sections. The presented results are meant to 
provide relative data on glial and vascular markers expression in all different experimental 
conditions but are not meant to be accurate estimates of absolute values.
Astrocyte reactivity by GFAP immunostaining
GFAP-stained sections were taken at 400x magnification and the area occupied by astrocytes 
was quantified, fixing a threshold of 120-140, and expressed as a percentage in relation to the total 
evaluated area. 
Microglial reactivity by CD11b immunostaining
CD11b-stained sections were taken at 400x magnification and the area occupied by microglial 
cells was quantified, fixing a threshold of 175-200, and expressed as a percentage in relation to the 
total evaluated area. 
Apoptotic cells by cresyl violet staining
The images were taken at 400x magnification and apoptotic cells were identified by delimited 
Nissl bodies’ accumulation, lacking cytoplasmic volume. Their number was manually quantified 
and expressed relative to 0.1mm2 of the brain area.
Vascular Network by von Willebrand Factor immunostaining
The vascular architecture analysis (200x magnification) was made as described in a previous 
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2) number of branching points and 3) vessels’ tortuosity, calculated as the ratio of the real distance 
between two consecutive branching points and the shortest distance between them (Fig. 2). This 
last parameter takes values from 1 to infinite, where higher values indicate a more sinuous 
structure. 
Immunofluorescence of HSP70
Fluorescence was quantified by mean gray value, assessed at three different sections on one 
isolated microvessel, and its final value was calculated as follows: section’s mean gray value - 
(background’s mean gray value + 3 standard deviation of background’s mean gray value); and 
expressed as Arbitrary Units of fluorescence intensity. The final value for each subject was the 
average from the measurements obtained in 6 images per rat at 400x magnification, where a 
maximum of 5 microvessels was analyzed in each picture. The same protocol was applied to AT1-
R quantification (Suppl. Fig 1).
Behavior
Holeboard test
The exploratory behavior was evaluated at a single-time exposure in an arena with 5 holes 
(arena: 60cm width x 60cm de long x 30cm de high; holes: 3cm diameter, 1 hole at the center, 4 
holes in the corners separated 10cm from the wall). Behavior was recorded and the number of 
head dipping into each hole was quantified for 5min. The data were analyzed and shown as 
described previously (Baiardi et al., 2007). For each animal in the experimental group, the number 
of visits was ordered from the most to the least visited holes. Attention deficit is considered as a 
significant difference between the two most explored holes.
Y-maze test
Animals were placed once at the center of a Y-shaped maze, with three equal arms (10cm width 
x 50cm long x 39cm tall, separated by 120º angle) and left for free exploration during 8min. The 
sequence of chosen entries was manually recorded and the percentage of alternations was 
calculated. With this purpose, three consecutive choices of three different arms were counted as an 
alternation, whereas the total possible alternations were calculated as the total number of entries 
minus 2. In this behavioral task, a lower alternation percentage is considered as an attention 
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Data were analyzed using one or two-way ANOVA and reported as means ± SEM. The 
analysis for two-way ANOVA considered Veh/CV as treatment factor and Sal/Amph as drug 
factor. If interaction and/or main effect were observed, multiple comparisons were made using the 
Tukey’s or Bonferroni's post-test. A value of p< 0.05 was considered significant. The analyses 
were performed using Graphpad Prism® 6.03 software. The artwork was conducted with Inkscape 
software (Free and Open Source Software licensed under the GPL). 
Results
AT1-R is involved in Amph-induced GFAP and CD11b increased expression, and vascular 
rearrangement in pre-limbic PFC  
Amph exposure promoted glial reactivity along with neuronal apoptosis in pre-limbic PFC. 
Moreover, long-term vascular rearrangement was observed as increased vascular density and 
tortuosity, and decreased branching points in this brain area. These events were prevented by 
previous AT1-R antagonism (Fig. 1 and 2).
Astrocyte reactivity was evidenced as increased GFAP-positive area in Veh-Amph group when 
compared to Veh-Sal group (treatment*drug interaction F(1, 22)=6.89, p= 0.015; Bonferroni post-
hoc p<0.05; Fig.1b); whereas no difference was found for CV-Amph group and control conditions. 
The same pattern and values were obtained after the Amph challenge, indicating no further change 
of astrocyte reactivity (data not shown). In the same direction, increased CD11b immunopositive 
area was evidenced in this brain area in Veh-Amph group, suggesting microglial reactivity after 
Amph exposure and its prevention by AT1-R blockade (treatment F(1, 25)=6.40 p= 0.018 and drug 
F(1, 25)=8.88p= 0.006; Fig.1c). 
Cresyl violet staining revealed deleterious effects of Amph exposure in this brain area as Veh-
Amph group showed a significantly elevated number of apoptotic cells when compared to Veh-Sal 
and CV-Amph groups (treatment F(1, 23)=7.94p= 0.0098, drug F(1, 23)=24.32p=0.0001 and 
treatment*drug interaction F(1, 23)=15.09 p= 0.0007; Bonferroni post-hoc p<0.05; Fig.1d).
When vascular network was analyzed, a vascular rearrangement was found in Veh-Amph group 
when compared to Veh-Sal and CV-Amph groups, evaluated by 3 parameters: 1. percentage of 
vascular area (treatment F(1, 27)=4.51 p= 0.043 and treatment*drug interaction F(1, 27)=11.30 p= 
0.0023); 2. vessels’ tortuosity (treatment F(1, 27)=5.88 p= 0.022, drug F(1, 27)=5.32 p= 0.029 and 
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F(1, 27)=9.60 p= 0.0045, drug F(1, 27)=7.67 p= 0.01 and treatment*drug interaction F(1, 27)=4.27 p= 
0.049). In all cases, Bonferroni comparison indicated p<0.05 for all parameters analyzed (Fig. 2).
Amph-induced glial and vascular alterations are region-specific
There were no changes in GFAP and CD11b immunoreactivity or vascular rearrangement in 
infra-limbic PFC after Amph exposure (Fig. 3). The results indicate no significant differences in 
the percentage of GFAP nor CD11b positive area (treatment*drug interaction F(1, 22)=3.29p=0.083 
and F(1, 27)=0.05 p= 0.83, respectively). However, 24h after the Amph challenge an increased 
GFAP positive area in Veh-Amph group was observed compared to Veh-Sal and CV-Amph 
groups (treatment*drug interaction F(1, 20)=7.85, p=0.011; Bonferroni post-hoc p<0.05, Table 1). 
In addition, no significant difference was observed in the percentage of vascular area of this brain 
area in basal conditions (treatment*drug interaction F(1, 26)=2.33p= 0.14).
The analyses of HPC (Fig. 4) indicated that there were no significant differences in the 
percentage of GFAP nor CD11b positive area (treatment*drug interaction F(1, 23)=0.00005 p= 0.99 
and F(1, 25)=0.00004 p=0.99, respectively). The same pattern and values were obtained after the 
Amph challenge for astrocyte reactivity (data not shown). In the same direction, in basal 
conditions, no significant difference was observed in the percentage of vascular area of this brain 
area (treatment*drug interaction F(1, 21)=0.72, p= 0.40).
Amph-induced attentional deficit involves AT1-R
The attentional deficit was observed as a lower performance in the two behavioral paradigms 
one week after the last Amph exposure. This deficit was not observed with the AT1-R blocker 
pretreatment (Fig. 5). Moreover, the Amph challenge masked the cognitive deficit observed in the 
Veh-Amph group (Fig. 6).  
For the holeboard test, there were significant differences in the head dipping into the holes (F(19, 
149)=15.15 p<0.0001). Tukey’s multiple comparisons indicated that Veh-Amph was the only group 
that showed significant differences in the number of head dipping between the first and the second 
most explored holes (p<0.05). After the Amph challenge, significant differences in the head 
dipping into the holes were found (F(19, 195)= 18.90 p<0.0001). However, in this case, Tukey’s 
multiple comparisons indicated no significant differences between the first and the second most 
explored holes in any of the experimental groups. Additionally, the results are shown as the 
difference in exploration percentage between the two more explored holes (insets in Figs. 4 and 5). 
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Sal) and CV pretreated animals (CV-Amph group) in basal conditions (treatment*drug interaction 
F(1, 30)=4.50 p=0.042; Bonferroni post-hoc p<0.05). After the Amph challenge, no differences were 
found among the four experimental groups (treatment*drug interaction F(1, 39)=1.25p= 0.27).
For the Y-maze test, Veh-Amph group showed a significantly lower alternation percentage than 
control group (Veh-Sal) and CV pretreated animals (CV-Amph group) in basal conditions (drug 
F(1, 53)=15.02 p= 0.0003 and treatment*drug interaction F(1, 53)=4.11 p= 0.048; Bonferroni post-hoc 
p<0.05). After the Amph challenge, no differences were found among the four experimental 
groups (treatment*drug interaction F(1, 32)=0.39 p= 0.53). 
Additional analyses were performed for the total activity during the behavioral test to discard 
motor differences among the four experimental groups (inset graphs in Fig. 5 and 6). For the 
holeboard test, there were no differences in the total number of head dipping, neither for basal 
conditions nor after the Amph challenge (treatment*drug interaction F(1, 30)=0.001 p= 0.97 and F(1, 
39)=1.16 p= 0.29, respectively). For the Y-maze test, the total arm entries showed no differences 
neither for basal conditions nor after the Amph challenge (treatment*drug interaction F(1, 53)=0.74 
p= 0.39 and F(1, 32)=3.84 p= 0.06, respectively). 
AT1-R is involved in Amph-induced oxidative and cellular stress in brain microvessels 
In brain microvessels, Amph long-term effects were observed as increased oxidative stress and 
cellular stress response evidenced by the Amph challenge (Fig. 7). AT1-R blockade prevented the 
development of this sensitized response. 
MDA content was not different among the four experimental groups in basal conditions 
(treatment*drug interaction F(1, 16)=1.82 p= 0.20); however, after the Amph challenge, Veh-Amph 
group showed significantly elevated MDA levels when compared to Veh-Sal and CV-Amph 
groups (treatment F(1, 17)=8.31 p= 0.01, drug F(1, 17)=12.19 p= 0.003 and treatment*drug 
interaction F(1, 17)=6.52 p= 0.02; Bonferroni post-hoc p<0.05).
In a similar way, Amph had no effect over HSP70 expression in basal conditions 
(treatment*drug interaction F(1, 15)=1.12 p= 0.31); whereas, after the Amph challenge, Veh-Amph 
group showed significantly elevated HSP70 expression when compared to Veh-Sal and CV-Amph 
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Glial reactivity and vascular network rearrangement induced by Amph exposure require AT1-R 
stimulation 
Our results indicate increased GFAP and CD11b positive area and apoptosis up to one week 
after Amph exposure in PFC (Fig. 1). Glial reactivity, observed as increased glial markers 
expression, has long been recognized as a specific marker for Amph toxicity (Ellison & Switzer, 
1993; Thomas et al., 2004). In this scenario, the transient increase in dopaminergic and 
glutamatergic neurotransmission has been proposed as the main effect of amphetamines’ 
detrimental effects (Yamamoto et al., 2010). Moreover, our results extend the Amph deleterious 
effects to the microvascular rearrangement in PFC (Fig. 2); supporting their region-specific 
toxicity as vascular network modifications are closely related to inflammatory processes (Costa et 
al., 2007). Similar vascular alterations have been previously described after Amph exposure 
(Occhieppo et al., 2017), chronic inflammatory disease (Dorr et al., 2012) and schizophrenia 
(Katsel et al., 2017). 
In addition, our results show that AT1-R is involved in the development of Amph-induced 
alterations in PFC, as its blockade prevented the increase in glial markers expression and the 
vascular rearrangement (Figs. 1-2). The role of AT1-R in Amph-induced alterations may be 
attributed to its multiple actions, including DA neurotransmission modulation (Jiang et al., 2018), 
dopaminergic neurons degeneration by oxidative stress, astrocyte and microglial reactivity and 
angiogenesis (Rodriguez-Pallares et al., 2008; Rodriguez-Perez et al., 2013; Labandeira-Garcia et 
al., 2014; Jiang et al., 2018). Particularly, in neuroinflammatory responses involving DA-
imbalance, the brain renin-angiotensin system is considered a key mediator in triggering glial cells 
activation with the subsequent progression of inflammation (Dominguez-Meijide et al., 2017). In 
the same direction, the protective effects of AT1-R blockade have been reported for the alterations 
on DA neurotransmission and toxicity induced by methamphetamine (Jiang et al., 2018). 
Considering vascular events, AngII has long been identified as a key factor in several types of 
angiogenesis via local AT1-R activation and subsequent vascular endothelial growth factor 
synthesis and release (Greene & Amaral, 2002; Tamarat et al., 2002). Although after ischemic 
injury, DA shows anti-angiogenic effects by decreasing AT1-R expression and activity (Sarkar et 
al., 2017), supporting the idea of an interplay between these two neuromodulatory systems. In this 
sense, blood flow regulation in PFC is highly dependent on the direct influence of DA over the 
local microvessels; whereas this area is the main and the first to express functional alterations 
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Amph-induced alterations and AT1-R involvement are region-specific
It is recognized that exposure to psychostimulants allows the identification of region-specific 
alterations (Ellison & Switzer, 1993). These alterations also include the angiotensinergic system 
since Amph or metamphetamine induce an increase in AT1-R expression and activity, in specific 
brain areas (Paz et al., 2014; Jiang et al., 2018). Interestingly, Amph affected the analyzed glial 
and vascular components selectively in the PFC; whereas none of the studied alterations were 
observed at HPC (Fig. 4). Moreover, even in PFC, we found differences between pre-limbic and 
infra-limbic subdivisions, because only this latter showed glial reactivity after the Amph challenge 
(Fig. 3- table 1). In the same direction, Amph detrimental effects (regarding ROS, inflammatory 
cytokines and dopaminergic degeneration) were described in limbic areas, whereas they were not 
detected in HPC (Belcher et al., 2005; Dietrich et al., 2005; Tan et al., 2012; Valvassori et al., 
2015; Jiang et al., 2018). On the contrary, vascular, glial and oxidative markers increase have been 
described in HPC after higher doses of Amph or a very short time after the last administration (i.e. 
after 24 hs); suggesting time- and dose-dependent alterations (de Souza et al., 2004; Che et al., 
2013; Hodes et al., 2018). Since the main long-lasting effect of Amph exposure is DA 
neurotransmission imbalance, PFC regional susceptibility could be triggered by its greater 
dopaminergic innervation (Sofuoglu, 2010).
Attentional deficit induced by Amph exposure and AT1-R role
The present study identifies an attention deficit in rats after Amph exposure concomitant with 
the morphological and structural changes of the non-neuronal cell types in PFC (Fig. 5). In this 
brain area, catecholamine neurotransmission is implicated in the coordination and integration of 
cues, even though they imply less complex behaviors (Jones, 2002; Arnsten, 2006). In this sense, 
attention is required when animals perform spatial recognition of novel environments; thus, 
behavioral tests evaluating exploration are indicative of PFC functional integrity, among other 
brain areas, such as HPC and other limbic structures (Lalonde, 2002; Dudchenko, 2004; Yabuki et 
al., 2014). The Amph-induced working memory deficit in rodents has been previously related to 
oligodendrocyte altered morphology in PFC, supporting the co-existence of functional and 
structural alterations in this brain area after Amph exposure (Yang et al., 2011). In the same 
direction, cortical hypo-perfusion, glial reactivity, inflammation and oxidative stress have been 
related to neuropsychiatric impairments in psychostimulant users, such as attention or decision- 
making deficits (Ornstein et al., 2000; Downey & Loftis, 2014). The PFC dysfunction described 
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glutamate and DA levels together with a diminished electrical activity (Lu & Wolf, 1999; Lu et 
al., 2010; Janetsian et al., 2015). This last evidence, could explain the improvement in the 
attention deficit after Amph challenge obtained in the present work (Fig. 6) because Amph induces 
catecholamine release (Arnsten, 1998). The proposed phenomenon is in accordance with the data 
obtained from Amph users that show improved attentional performance after re-exposure to low 
doses of the stimulant (Mahoney et al., 2011). Additionally, we previously showed an increased 
hippocampal synaptic plasticity and resistance to the interference of long-term memory 
consolidation by using the same experimental protocol (Marchese et al., 2016). 
Remarkably, AT1-R blockade prevented the development of Amph-induced attention deficit 
and a similar protective effect has been described in the development of cognitive deficits 
(Marchese et al., 2016), as well as in neuroinflammatory scenarios in different animal models 
(Mogi et al., 2007; Sharma & Singh, 2012; Sun et al., 2015); whereas a deleterious interplay 
between AT1-R activation and  DA degeneration takes place in the striatum (Jiang et al., 2018) 
along with cognitive deficits in senescence (Villar-Cheda et al., 2014). 
Amph-induced oxidative and cellular stress in brain microvessels: AT1-R role 
In our findings, the long-term effects of Amph exposure over brain microvascular responses are 
observed as sensitized oxidative stress and HSP70 expression, elicited by the Amph challenge 
(Fig. 7). It has been previously reported that a single non-toxic dose of Amph increases the 
expression of inflammatory and cellular stress genes in the meninges-associated vasculature, up to 
24hs after drug exposure (Thomas et al., 2009; Thomas et al., 2010). However, from our 
knowledge, no evidence has been previously reported after Amph exposure regarding sensitized 
oxidative/inflammatory responses in brain microvessels. Furthermore, there is an established link 
between elevated ROS levels and further stimulating HSP70 synthesis as a protective response to 
apoptotic signaling (Horowitz & Robinson, 2007; Lee et al., 2015). Additionally, we found no 
sensitized response to the Amph challenge in brain microvessels obtained from animals pretreated 
with AT1-R blocker. In complementary experiments, we found that a basal increase in AT1-R 
expression might trigger the sensitized response (in brain microvessels after Amph-exposure, 
Suppl. Fig. 1) given that a similar increase in HSP70 levels was observed after the AngII 
intracerebroventricular challenge (Suppl. Fig. 2). Particularly, AT1-R up-regulation in SHR brain 
microvessels has been related to increased levels of heat shock family components, pro-
inflammatory mediators and endothelial imbalance of NO and ROS levels (Ando et al., 2004; 
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Conclusion  
Our results bring into focus a sensitized brain vascular response long after Amph exposure and 
support the proposal that a compromised vasculature could be involved in the deleterious 
conditions, described for Amph users or chronic Amph treatments (Berman et al., 2009; Carvalho 
et al., 2012). Vascular alterations are considered triggering events for several inflammatory 
conditions in the CNS, as they would affect local metabolic demands and neuronal functioning 
(Tesfamariam & DeFelice, 2007; Iadecola, 2010; El Assar et al., 2013). The brain region specific 
long-lasting changes in glial reactivity and vascular network rearrangement could imply an 
increased susceptibility to local alterations. Finally, the involvement of AT1-R in the enduring 
deleterious microenvironment encourages further studies focusing on AngII system in the 
development and progression of neuroinflammatory pathologies. 
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Table 1. Astrocyte reactivity in infra-limbic prefrontal cortex. 
  Saline  Amphetamine 
  GFAP+ AREA (%) n GFAP+ AREA (%) n 
Vehicle 1,62 ± 0,4 6 4,23 ± 0,69 * 6 
Candesartan 1,82 ± 0,43 6 1,85 ± 0,12 6 
The table shows astrocyte reactivity as GFAP positive area (%) in the four experimental 
groups, after the amphetamine challenge on day 17. Values are the mean±SEM; *different 
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Fig. 1. Glial activation in pre-limbic prefrontal cortex. Schematic representation of the experimental 
protocol (a). The graphs show astrocyte reactivity by GFAP positive area (b), microglial activation by CD11b 
positive area (c) and the number of apoptotic cells by cresyl violet staining (d) in the four experimental 
groups. Values are the mean±SEM; *different from control group (p= 0.020) (b), # significant effect for 
treatment and + significant effect for drug (c), *different from control (p< 0.0001) and CV-Amph group (p= 
0.0004) (c); n= 5-8. 
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Fig. 2. Vascular network characteristics in prefrontal cortex. The microphotographs are 
representative of von Willebrand factor staining and show the parameters analyzed (a). Vascular network 
was evaluated considering: the percentage of vascular area (b), vessels’ tortuosity (c) and the number of 
branching points (d). Values are the mean±SEM for the four experimental groups in basal conditions; 
*different from control (p= 0.014; p= 0.022; p= 0.010; for each parameter) and CV-Amph groups (p= 
0.0030; p= 0.018; p= 0.0056; for each parameter), n= 7-8. 
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Fig. 3. Structural characteristics in infra-limbic prefrontal cortex. The graphs show GFAP positive 
area (n= 6-8) (a), CD11b positive area quantification (n=7-8) (b) and vascular network considering 
percentage of vascular area (n=7-8) (c). Values are the mean±SEM for the four experimental groups. 
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Fig. 4. Structural characteristics in hippocampus. The graphs show GFAP positive area (n= 5-8) (a), 
CD11b positive area quantification (n=6-8) (b) and vascular network considering percentage of vascular 
area (n=6-7) (c). Values are the mean±SEM for the four experimental groups. 
This article is protected by copyright. All rights reserved 
 
Fig. 5. Behavioral evaluation of attention performance- saline challenge. Schematic representation 
of the experimental protocol (a). Head dipping number during exploration in the holeboard test (n= 8-9). 
Hole exploration is ordered from the most to the least visited hole for each experimental group; * different 
from the most explored hole (1st) (p<0.0001). The left inset shows the difference in exploration percentage 
(%) between the two more explored holes; *different from control (p=0.031) and CV-Amph group (p= 
0.021). The right inset shows the total head dipping (nº) during holeboard test (b). Percentage of 
alternations in the Y-maze test for the four experimental groups; *different from control (p=0.0003) and 
CV-Amph group (p= 0.022). The inset shows the total entries (nº) (n= 12-16) (c). Values are the 
mean±SEM. 
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Fig. 6. Behavioral evaluation of attention performance- amphetamine challenge. Schematic 
representation of the experimental protocol (a). Head dipping number during exploration in the holeboard 
test (n= 10-12). The exploration to the holes is ordered from the most to the least visited hole for each 
experimental group. The left inset shows the difference in exploration percentage (%) between the two 
more explored holes. The right inset shows the total head dipping (nº) during holeboard test (b). 
 Percentage of alternations in the Y-maze test for the four experimental groups, the inset shows the total 
entries (nº) (n= 8-10) (c). Values are the mean±SEM. 
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Fig. 7. Oxidative and cellular stress in brain microvessels. Schematic representation of the 
experimental protocol (a). The upper panel graphs show MDA levels in brain microvessels, in the four 
experimental groups, after the Amph challenge; *different from control (p= 0.0025) and CV-Amph group 
(p= 0.0065) (n=5-6). Unchanged values with saline challenge are shown in the inset, (n= 4-6) (b). HSP70 
quantification after the Amph challenge; *different from control (p= 0.021) and CV-Amph group (p= 0.023) 
(n=4-5). Unchanged values with saline challenge are shown in the inset, (n= 4-5) (c). The 
microphotographs are representative of HSP70 expression in the four experimental groups receiving the 
Amph challenge (d). Values are the mean±SEM. 
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